Lexeo Therapeutics, Inc. Ratios

Ratios Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -9,063.76%32,387.32%71,775.91%
EBIT Margin -9,252.14%33,420.98%77,201.46%
EBITDA Margin -9,252.14%32,387.32%71,851.09%
Operating Margin -9,252.14%33,420.98%77,201.46%
Net Margin -9,063.76%32,387.32%71,775.91%
FCF Margin -8,445.26%29,078.54%59,585.40%
Efficiency
Invested Capital -112.95M
Leverage & Solvency
Interest Coverage Ratio -664.93-334.21-772.01
Equity Ratio -1.16
Times Interest Earned -664.93-334.21-772.01
Valuation
Enterprise Value -77.33M357.58M217.57M
Market Capitalization 357.58M217.57M
Return Ratios
Return on Sales -90.64%323.87%717.76%